Literature DB >> 4251631

Human serum plasminogen antiactivator: its distinction from antiplasmin.

N Aoki, K N Von Kaulla.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1971        PMID： 4251631     DOI： 10.1152/ajplegacy.1971.220.4.1137

Source DB:  PubMed          Journal:  Am J Physiol        ISSN： 0002-9513


× No keyword cloud information.
  6 in total

Review 1.  [The enzymatic linkage of fibrinogenesis and fibrinolysis (author's transl)].

Authors:  R E Zimmermann; J Lubinus
Journal:  Klin Wochenschr       Date:  1978-08-15

2.  The primary inhibitor of plasmin in human plasma.

Authors:  S Müllertz; I Clemmensen
Journal:  Biochem J       Date:  1976-12-01       Impact factor: 3.857

3.  Increased plasminogen activator (urokinase) in tissue culture after fibrin deposition.

Authors:  M B Bernik
Journal:  J Clin Invest       Date:  1973-04       Impact factor: 14.808

4.  Effects of vasoactive intestinal polypeptide on intestinal absorption and blood flow.

Authors:  D Mailman
Journal:  J Physiol       Date:  1978-06       Impact factor: 5.182

5.  The behavior of alpha2-plasmin inhibitor in fibrinolytic states.

Authors:  N Aoki; M Moroi; M Matsuda; K Tachiya
Journal:  J Clin Invest       Date:  1977-08       Impact factor: 14.808

6.  Effects of glucagon on canine intestinal sodium and water fluxes and regional blood flow.

Authors:  S N MacFerran; D Mailman
Journal:  J Physiol       Date:  1977-03       Impact factor: 5.182
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.